September & November 2020

Written By Daniel Quay

We provided extensive feedback on the National Institute for Health and Care Excellence (NICE) Chronic Pain Assessment and Management Guideline proposed in the United Kingdom, responded to calls for public comment from the Drug Enforcement Agency and the Oregon Health Authority, and offered solicited testimony during state opioid hearings in Minnesota.

Daniel Quay
Previous

December 2020
Next

July 2020